Better tools to study the processes of life
Scientists have developed a new biological tool for examining molecules - the building blocks of life - which they say could provide new insights and other benefits such as reducing the numbers of animals used in experiments.
The image shows an antibody (Blue object) and affimer (orange object) to demonstrate the size and complexity differences.
Avacta Life Sciences
The University of Leeds in collaboration with Avacta Life Sciences, a Leeds spin-out company has developed tools, called Affimer technology, which can replicate the work of animal-derived antibodies traditionally used to help study biological molecules and processes.
Like antibodies, Affimer technology can bind tightly to a target molecule to help scientists study its actions. However, Affimer proteins are superior in being more robust, smaller, easier to modify to suit different applications and more specific to the target of interest.
Research explains how Affimer tools can be produced in a matter of weeks, rather than the many months it can take to create a high quality antibody.
Dr Darren Tomlinson, from the Astbury Centre for Structural Molecular Biology and BioScreening Technology Group at the University of Leeds, said: "Molecules are notoriously difficult to study and therefore tools are required that allow molecules behaviour to be studied indirectly. Such tools, like Affimer technology provides an easy and more reliable way to track molecules movements and study how they react to different stimuli which will make the study of diseases they can cause much easier."
Current research methods For many years researchers have used animal-derived antibodies to indicate the presence of biological molecules and to study how they work.
While for a long time these were the best available option, the reliance on animals to create them, and difficulties in producing batches of antibodies which behave in the same way has proved problematic.
The Affimer tools developed by the Leeds-led team, led by Professor Mike McPherson and Dr Tomlinson, supported by researchers from Avacta Life Sciences, the Rutherford Appleton laboratory, Pirbright Institute, Defence Science and Technology Laboratory and the Oxford Protein Production Laboratory is an example of the emerging method of creating 'alternative binding proteins' which replicate the work of antibodies using lab created tools.
The team showed that the Affimer technology worked well in a wide range of different routine procedures in which antibodies are normally used by scientists.
They found it produced similar quality results and, in a new technique called 'super-resolution microscopy' its smaller size meant scientists were able to look more closely at what individual molecules were doing.
The team demonstrated how Affimer tools could help scientists:
- Understand how a particular molecule works within a cell,
- How it can help create detailed pictures of molecules in cells and tissues
- Identify a cancer tumour
The ability to develop the Affimer tools without relying on animals also helps to reduce the number used in research work, an example of the University's commitment to finding new ways to lower the number of animals involved in scientific studies.
The University of Leeds is a signatory to the Concordat on Openness in Animal Research run by Understanding Animal Research and supports the National Council for the Replacement, Reduction and Refinement of Animals in Research.
Dr Tomlinson added: "Affimer tools are more reliable than animal-based antibodies and as they are made in the lab and not through the use of animals we have created a scientifically-sound and animal friendly alternative for researchers to use.
"Animals play a vital role in research which helps us learn about life and disease processes, but advances in scientific procedures mean there are in some cases alternatives to using them, or using them alongside new methods, which is pleasing."
"Affimer tools are much less complicated and more stable than antibodies", said Dr Christian Tiede, first author on the research paper which covers its development. "They can easily be adapted for a wide variety of uses; together with antibodies, they provide important tools in biology, biotechnology and medicine."
Original publication
Other news from the department science
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
